Helix Peptide Achieves ISO 9001:2015 Recertification
Our quality management system has been recertified with zero major non-conformances, reinforcing our commitment to manufacturing excellence.
Continuous Improvement in Quality Management
Helix Peptide has successfully completed its ISO 9001:2015 surveillance audit with zero major non-conformances and two minor observations that were resolved during the audit week.
Audit Scope
The recertification covered our entire peptide manufacturing operation:
- Solid-phase peptide synthesis (SPPS) and purification
- Analytical method development and release testing
- Document control and change management
- Supplier qualification and incoming material inspection
- Customer complaint handling and CAPA processes
Key Quality Metrics (2025)
| Metric | Result | |--------|--------| | On-time delivery | 97.2% | | First-pass COA acceptance | 99.1% | | Customer complaint rate | 0.3% | | CAPA closure within 30 days | 100% |
What This Means for Buyers
ISO 9001 recertification confirms that Helix Peptide maintains a robust, auditable quality system across all product grades — from Research to GMP. Partners conducting vendor qualification can request:
- Current ISO 9001 certificate
- Quality manual summary
- Vendor audit questionnaire (pre-completed)
- Reference client contacts (under NDA)
Contact our quality assurance team at qa@helixpeptide.com for documentation requests.